As of 2025-10-20, the Relative Valuation of Krystal Biotech Inc (KRYS) is 125.71 USD. This relative valuation is based on P/E multiples. With the latest stock price at 190.23 USD, the upside of Krystal Biotech Inc based on Relative Valuation is -33.9%.
The range of the Relative Valuation is 83.54 - 177.45 USD.
| Range | Selected | |
| Trailing P/E multiples | 29.9x - 35.0x | 32.4x |
| Forward P/E multiples | 32.4x - 35.0x | 33.7x |
| Fair Price | 83.54 - 177.45 | 125.71 |
| Upside | -56.1% - -6.7% | -33.9% |
| Date | P/E |
| 2025-10-17 | 37.52 |
| 2025-10-16 | 37.15 |
| 2025-10-15 | 38.07 |
| 2025-10-14 | 37.09 |
| 2025-10-13 | 36.44 |
| 2025-10-10 | 35.79 |
| 2025-10-09 | 37.23 |
| 2025-10-08 | 36.92 |
| 2025-10-07 | 36.10 |
| 2025-10-06 | 35.62 |
| 2025-10-03 | 36.17 |
| 2025-10-02 | 35.84 |
| 2025-10-01 | 35.43 |
| 2025-09-30 | 34.82 |
| 2025-09-29 | 34.86 |
| 2025-09-26 | 33.10 |
| 2025-09-25 | 31.79 |
| 2025-09-24 | 31.95 |
| 2025-09-23 | 32.54 |
| 2025-09-22 | 32.63 |
| 2025-09-19 | 32.26 |
| 2025-09-18 | 31.68 |
| 2025-09-17 | 30.38 |
| 2025-09-16 | 30.45 |
| 2025-09-15 | 30.71 |
| 2025-09-12 | 28.34 |
| 2025-09-11 | 28.47 |
| 2025-09-10 | 27.11 |
| 2025-09-09 | 27.85 |
| 2025-09-08 | 28.64 |
| 2025-09-05 | 29.64 |
| 2025-09-04 | 29.54 |
| 2025-09-03 | 29.63 |
| 2025-09-02 | 29.39 |
| 2025-08-29 | 29.13 |
| 2025-08-28 | 29.74 |
| 2025-08-27 | 29.12 |
| 2025-08-26 | 28.97 |
| 2025-08-25 | 28.95 |
| 2025-08-22 | 29.68 |
| 2025-08-21 | 28.74 |
| 2025-08-20 | 28.77 |
| 2025-08-19 | 28.39 |
| 2025-08-18 | 28.86 |
| 2025-08-15 | 29.64 |
| 2025-08-14 | 29.65 |
| 2025-08-13 | 29.46 |
| 2025-08-12 | 28.33 |
| 2025-08-11 | 27.13 |
| 2025-08-08 | 27.35 |